Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / About EDRN / Scientific Components

Scientific Components

The components and projects that comprise the Early Detection Research Network.
  • Biomarker Development Laboratories

    Responsible for the development and characterization of new biomarkers or the refinement of existing biomarkers.

  • Biomarker Reference Laboratories

    Serve as a Network resource for clinical and laboratory validation of biomarkers, which includes technological development, quality control, refinement, and high throughput.

  • Clinical Validation Centers

    Conduct clinical and epidemiological research regarding the clinical application of biomarkers.

  • Data Management and Coordinating Center

    Coordinates the EDRN research activities, providing logistic support, and conducting statistical and computational research for data analysis, analyzing data for validation. Also responsible for EDRN common database development.

  • Informatics Center

    The Informatics Center supports EDRN's efforts through the development of software systems for information management. The center is at the NASA Jet Propulsion Laboratory at the California Institute of Technology.

Announcement 04/26/2017

A new funding opportunity associated with the Beau Biden Cancer Moonshot Initiative, Integration and Validation of Emerging Technologies to Accelerate Cancer Research, has been released and is due May 10, 2017. Click here for more information.

Announcement 03/14/2017

Thank you to everyone who made the March 2017 EDRN Steering Committee Meeting a success. The next EDRN Steering Committee Meeting will be on September 12-14, 2017, in Seattle, WA.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.